Modelling the risk-benefit impact of H1N1 influenza vaccines

European Journal of Public Health

Volumn 23, Issue 4, 2013, Pages 674-678

  Phillips, Lawrence D ^a,b   Fasolo, Barbara ^a,b   Zafiropoulous, Nikolaos ^a   Eichler, Hans Georg ^a   Ehmann, Falk ^a   Jekerle, Veronika ^a   Kramarz, Piotr ^c   Nicoll, Angus ^c   Lönngren, Thomas ^d  

^a EUROPEAN MEDICINES AGENCY   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^d NDA Advisory Services Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

DECISION MAKING; DECISION TREE; HUMAN; IMMUNOLOGY; INFLUENZA VIRUS A H1N1; INFLUENZA, HUMAN; PANDEMICS; PROCEDURES; PUBLIC HEALTH; RISK ASSESSMENT; THEORETICAL MODEL; ARTICLE; INFLUENZA; METHODOLOGY; PANDEMIC;

DECISION MAKING; DECISION TREES; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MODELS, THEORETICAL; PANDEMICS; PUBLIC HEALTH; RISK ASSESSMENT;

EID: 84880898676     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/ckt006     Document Type: Article

References (18)

1. Goodwin P, Wright G. Decision Analysis for Management Judgment, 4th edn. Chichester: John Wiley, 2009
2. Zarocostas J. World Health Organization declares A (H1N1) influenza pandemic. Br Med J 2009;338:b2425
3. Phillips LD. Decision conferencing. In: Edwards W, Miles RF, von Winterfeldt D, editors. Advances in Decision Analysis: From Foundations to Applications. Cambridge: Cambridge University Press, 2007
4. O'Hagan A, Buck CE, Daneshkhah A, et al. Uncertain Judgements: Eliciting Experts' Probabilities. Chichester: John Wiley & Sons, 2006
5. Johnson NP, Mueller J. Updating the accounts: Global mortality of the 1918-1920 ''Spanish'' influenza pandemic. Bull Hist Med 2002;76:105-15
6. Cabinet Office, Department of Health. Swine Flu: UK Planning Assumptions. London: Cabinet Office, Department of Health, 2009
7. Vaillant L, La Ruche G, Tarantola A, Barboza P. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Eurosurveillance 2009;14:1-6
8. Morens DM, Taubenberger JK. Understanding influenza backward. J Am Med Assoc 2009;302:679-80
9. Fiore AE, Bridges CB, Cos NJ. Seasonal influenza vaccines. In: Compans RW, Orenstein WA, editors. Vaccines for Pandemic Influenza. Berlin Heidelberg: Springer, 2009: 43-82
10. Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, et al. Guillan-Barre Syndrome following vaccination in the national influenza immunization program, United States, 1976-1977. Am J Epidemiol 1979;110:105-23
11. Vellozzi C, Burwen DR, Dobardzic A, et al. Safety of trivalent inactivated influenza vaccines in adults: Background for pandemic influenza vaccine safety monitoring. Vaccine 2009;27:2114-20
12. Treanor JJ, Campbell MD, Zangwill KM, et al. Safety and immunogenecity of an inactivated subvirion influence A (H5N1) vaccine. N Engl J Med 2006;354: 1343-51
13. Howard RA, Matheson JE. Influence diagrams. Decis Anal 2005;2:127-43
14. Raiffa H. Decision Analysis. Reading, MA: Addison-Wesley, 1968
15. Miller GA. The magical number seven, plus or minus two: Some limits on our capacity of processing information. Psychol Rev 1956;63:81-97
16. Tversky A, Kahneman D. Judgment under uncertainty: Heuristics and biases. Science 1974;185:1124-31
17. Lichtenstein S, Slovic P, editors. The Construction of Preference. New York, NY: Cambridge, 2006
18. Gregory R, Lichtenstein S, Slovic P. Valuing environmental resources: A constructive approach. J Risk Uncertain 1993;7:177-97